Psychometric Properties of the Chinese Version of the Bipolar Depression Rating Scale for Bipolar Disorder

Código QR

Psychometric Properties of the Chinese Version of the Bipolar Depression Rating Scale for Bipolar Disorder

Jing-Xu Chen,1,* Lu Yin,1,* Hai-Ting Xu,1 Suo-Yuan Zhang,1 Wen-Qian Huang,1 Hong-Juan Li,1 Bin-Bin Li,1 Ke-Bing Yang,1 Qian Li,2 Michael Berk,3 Yun-Ai Su2 1Beijing HuiLongGuan Hospital, Peking University HuiLongGuan Clinical Medical School, Beijing, 100096, People’s Republic of China; 2Pek...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chen JX, Yin L, Xu HT, Zhang SY, Huang WQ, Li HJ, Li BB, Yang KB, Li Q, Berk M, Su YA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	bipolar disorder mania depression psychometrics depressive episode rating scale psychiatry Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/0d69a927feee48a3af8aa0ae420cdb5c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Asenapine for bipolar disorder
por: Scheidemantel T, et al.
Publicado: (2015)

Comparing the Self- and External Assessment Versions of the HCL-33 as Screening Instruments for Bipolar Disorder in Older Depressed Patients
por: Xinqiao Zhang, et al.
Publicado: (2021)

A Pilot Study Differentiating Recurrent Major Depression from Bipolar Disorder Cycling on the Depressive Pole [Retraction]
por: Hinz M, et al.
Publicado: (2020)

A Pilot Study Differentiating Recurrent Major Depression from Bipolar Disorder Cycling on the Depressive Pole [Expression of Concern]
por: Hinz M, et al.
Publicado: (2020)

Effects of the COVID‐19 pandemic in a preexisting longitudinal study of patients with recently diagnosed bipolar disorder: Indications for increases in manic symptoms
por: Manja Koenders, et al.
Publicado: (2021)

Mania and bipolar depression: complementing not opposing poles—a post-hoc analysis of mixed features in manic and hypomanic episodes
por: Christoph Born, et al.
Publicado: (2021)

Association between anxious distress in a major depressive episode and bipolarity
por: Sugawara H, et al.
Publicado: (2019)

Perceptions and impact of bipolar disorder in Japan: results of an Internet survey
por: Watanabe K, et al.
Publicado: (2016)

Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts RJ, et al.
Publicado: (2016)

Lithium Preparations in Psychiatry, Addiction Medicine and Neurology (To the 70th Anniversary of John Cade’s Discovery). Part I. History
por: Roman A. Bekker, et al.
Publicado: (2019)

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression
por: Ni P, et al.
Publicado: (2021)

Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression
por: Zhang W, et al.
Publicado: (2020)

Editorial: The Role of Resilience and the Interplay Between Genetics and Environment in Bipolar Disorder
por: Bianca Pfaffenseller, et al.
Publicado: (2021)

Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
por: Yalin N, et al.
Publicado: (2020)

Psychometric Properties of the HADS Measure of Anxiety and Depression Among Multiple Sclerosis Patients in Croatia
por: Ana Jerković, et al.
Publicado: (2021)

Similar and Different Regional Homogeneity Changes Between Bipolar Disorder and Unipolar Depression: A Resting-State fMRI Study
por: Liu P, et al.
Publicado: (2020)

Bipolar disorders
Publicado: (1999)

The Prevalence of Sarcopenia in Bipolar Disorder
por: Bulbul F, et al.
Publicado: (2020)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska A, et al.
Publicado: (2021)

Effect of medication therapy combined with transcranial direct current stimulation on depression and response inhibition of patients with bipolar disorder type I: a clinical trial
por: Parnaz Mardani, et al.
Publicado: (2021)

Thyroid functions in patients with bipolar disorder and the impact of quetiapine monotherapy: a retrospective, naturalistic study
por: Li C, et al.
Publicado: (2019)

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
por: Wang G, et al.
Publicado: (2016)

International journal of bipolar disorders
Publicado: (2013)

The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double‐blind, randomized, placebo‐controlled, clinical trial
por: Rahim Badrfam, et al.
Publicado: (2021)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle R, et al.
Publicado: (2016)

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder
por: Bo Q, et al.
Publicado: (2019)

Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
por: Maneeton B, et al.
Publicado: (2017)

QT and P-wave dispersion during the manic phase of bipolar disorder
por: Gurok MG, et al.
Publicado: (2019)

Differences in verbal and spatial working memory in patients with bipolar II and unipolar depression: an MSI study
por: Zhinan Li, et al.
Publicado: (2021)

Screening for bipolar disorder among migraineurs: the impact of migraine–bipolar disorder comorbidity on disease characteristics
por: Kivilcim Y, et al.
Publicado: (2017)

Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
por: Inoue T, et al.
Publicado: (2020)

Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder
por: Citrome L, et al.
Publicado: (2017)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Borjanka Batinic, et al.
Publicado: (2021)

Suicidality and symptoms of anxiety, irritability, and agitation in patients experiencing manic episodes with depressive symptoms: a naturalistic study
por: Eberhard J, et al.
Publicado: (2016)

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
por: Husain MI, et al.
Publicado: (2016)

Assessment of the Hospital Anxiety and Depression Scale for cancer patients
por: Villoria,Erica, et al.
Publicado: (2018)

Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
por: Zvěřová M, et al.
Publicado: (2019)

Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia
por: Puspitasari IM, et al.
Publicado: (2020)

The Association Between Concentrations of Arginine, Ornithine, Citrulline and Major Depressive Disorder: A Meta-Analysis
por: Mingyue Fan, et al.
Publicado: (2021)

Comparative Study of Cognitive Function Between Treatment-Resistant Depressive Patients and First-Episode Depressive Patients
por: Rao D, et al.
Publicado: (2019)